Cross-reactive antibodies induced by a monovalent influenza B virus vaccine.

AUTOR(ES)

Levandowski, R A

RESUMO

Influenza viruses related to the markedly antigenically divergent strains B/Yamagata/16/88 and B/Victoria/2/87 are circulating in human populations. Adults develop cross-reacting antibodies against recent and earlier influenza B virus strains after vaccination with B/Yamagata/16/88, probably because of previous influenza B virus infections or immunizations. Vaccines containing B/Yamagata/16/88 should adequately protect adults against B/Victoria/2/87 infections.

Documentos Relacionados

• Production of highly cross-reactive hemagglutination-inhibiting influenza antibodies in ferrets.
• Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.
• Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
• Cross-reactive idiotypes in immunoglobulin A-deficient sera.
• Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies.